{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:41:43Z","timestamp":1749962503141,"version":"3.40.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00277-020-04191-3","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T01:02:45Z","timestamp":1595466165000},"page":"2201-2203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study"],"prefix":"10.1007","volume":"99","author":[{"given":"Francesca","family":"Bettelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Colaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Nasillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Pioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gilioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Iotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Giubbolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Colasante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Catellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Barozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Lagreca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Vallerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Banchelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Narni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Comoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-1420","authenticated-orcid":false,"given":"Fabio","family":"Forghieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"4191_CR1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2014.026","volume":"6","author":"L Anibarro","year":"2014","unstructured":"Anibarro L, Pena A (2014) Tuberculosis in patients with haematological malignancies. Mediterr J Hematol Infect Dis 6:e2014026. https:\/\/doi.org\/10.4084\/MJHID.2014.026","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4191_CR2","first-page":"1110","volume":"90","author":"FA Silva","year":"2005","unstructured":"Silva FA, Matos JO, de Q Mello FC, Nucci M (2005) Risk factors for and attributable mortality from tuberculosis in patients with hematological malignancies. Haematologica 90:1110\u20131115","journal-title":"Haematologica"},{"key":"4191_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/cid\/ciz048","volume":"69","author":"MP Cheng","year":"2019","unstructured":"Cheng MP, Kusztos AE, Bold TD, Ho VT, Glotzbecker BE, Hsieh C, Baker MA, Baden LR, Hammond SP, Marty FM (2019) Risk of latent tuberculosis reactivation after hematopoietic-cell transplantation. Clin Infect Dis 69:869\u2013872","journal-title":"Clin Infect Dis"},{"key":"4191_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/cid\/cix209","volume":"64","author":"MP Cheng","year":"2017","unstructured":"Cheng MP, Abou Chakra C, Yansouni CP, Cnossen S, Shrier I, Menzies D, Greenaway C (2017) Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis. Clin Infect Dis 64:635\u2013644","journal-title":"Clin Infect Dis"},{"key":"4191_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13513","volume":"33","author":"AK Subramanian","year":"2019","unstructured":"Subramanian AK, Theodoropoulos NM (2019) Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases Community of Practice of the America Society of Transplantation. Clin Transpl 33:e13513","journal-title":"Clin Transpl"},{"key":"4191_CR6","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Bin-Eng Chee C, Chesire L, Corbett E, Dara M, Denholm J, De Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go U, Govindasamy D, Grant AD, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, L\u00f6nnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren S, Sa\u00f1\u00e9Schepisi M, Sch\u00fcnemann HJ, Kumar Sharma S, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van\u2019t Hoog A, Varma JK, Vezhnina N, Voniatis C, Noordegraaf-Schouten MV, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M (2015) Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 46:1563\u20131576","journal-title":"Eur Respir J."},{"key":"4191_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1378\/chest.08-2575","volume":"136","author":"L Richeldi","year":"2009","unstructured":"Richeldi L, Losi M, D\u2019Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B, Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunga GE, Torelli G, Esposito R, Fabbri LM (2009) Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136:198\u2013204","journal-title":"Chest"},{"key":"4191_CR8","doi-asserted-by":"publisher","unstructured":"Park JH, Choi EJ, Park HS, Choi SH, Lee SO, Kim YS, Woo JH, Lee JH, Lee JH, Lee KH, Shim TS, Kim SH (2020) Treatment of latent tuberculosis infection based on the interferon-gamma releasing assay in allogeneic stem cell transplant recipients. Clin Infect Dis:pii: ciaa030. https:\/\/doi.org\/10.1093\/cid\/ciaa030","DOI":"10.1093\/cid\/ciaa030"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04191-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04191-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04191-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:22:30Z","timestamp":1626996150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04191-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04191-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"FF served on advisory boards for Jannsen on the clinical use of decitabine, for Novartis on the clinical use of midostaurin and received travel grants from Jazz Pharmaceuticals. ML served on advisory boards for Novartis on the clinical use of midostaurin, for AbbVie, on the clinical use of venetoclax, for Jazz Pharmaceuticals, on the clinical use of Vyxeos, for Gilead Sci., on the clinical use of Ambisome, for MSD, on the clinical use of letermovir, for Sanofi, on the clinical use of caplacizumab, from Daiichi-Sankyo, for the clinical use of quizartinib and received travel grants from Gilead Sci. ML, LP, and PB have applied for an Italian patent regarding clinical applications of the ELISpot assay for the diagnosis of Aspergillus infection [PCT: WO2008\/075395A3, IT2007\/000867]. ML, LP, DV, PB, and FF have applied for an Italian and US patent regarding clinical applications of the ELISpot assay for the diagnosis of Mucorales infection [PCT:WO2012073160 A1, IT MI20102224, US 2013\/0260395]. The other authors have no conflicts of interest to declare, relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from alive patients, according to the Declaration of Helsinki, and after local Ethical Committee study approval (Protocol no. 1345-63\/11). Data collected from medical records were described as either medians or means with standard deviations (quantitative variables) or absolute and percentage frequencies (categorical variables). The possible associations between pre-defined patients characteristics and probability of Quantiferon\u00ae-TB positivity were evaluated using a multinomial logit regression model. The potential association between Quantiferon\u00ae-TB results and probability of death during remission induction therapy was evaluated using a logistic regression model. Furthermore, the association between Quantiferon\u00ae-TB results and the number of either pneumonias during induction cycle or infections during whole treatment duration was evaluated using a negative binomial regression model. All the results were expressed as odds ratio (OR) with 95% confidence interval and <i>p<\/i> value. The analyses were performed with R 3.4.3 statistical software (The R Foundation for Statistical Computing, Wien) at <i>p<\/i>\u2009<\u20090.05 level of significance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}